Overview

Evaluation of Abbreviated Versus Conventional Course of Dabigatran Etexilate Before Electric Cardioversion in Patients With Atrial Fibrillation (RE-SOUND Study)

Status:
Unknown status

Trial end date:
2020-12-30

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the efficacy of abbreviated 3-day anticoagulation with dabigatran etexilate before cardioversion guided by trans-oesophageal echocardiography in comparison with conventional 3- week course of dabigatran etexilate before cardioversion

Phase:

Phase 4

Details

Lead Sponsor:

Ural Medical University
Ural State Medical University

Collaborator:

Boehringer Ingelheim

Treatments:

Dabigatran